Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Monegal

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Seminars in Arthritis and Rheumatism|September 10, 2002
Clinical characteristics and etiologic factors of premenopausal osteoporosis in a group of Spanish womenPilar Peris, Núria Guañabens, Ma Jesús Martínez de Osaba, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 9, 2014
Effect of recent spinal cord injury on wnt signaling antagonists (sclerostin and dkk-1) and their relationship with bone loss. A 12-month prospective studyLaia Gifre, Joan Vidal, Josep L Carrasco, et al.
Endocrine|October 22, 2010
The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblastsAnna Enjuanes, Silvia Ruiz-Gaspà, Pilar Peris, et al.
Endocrine|October 21, 2010
The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblastsAnna Enjuanes, Silvia Ruiz-Gaspà, Pilar Peris, et al.
Menopause (New York, N.Y.)|July 14, 2009
Search for hidden secondary causes in postmenopausal women with osteoporosisDacia Cerdá Gabaroi, Pilar Peris, Ana Monegal, et al.
Transplantation|April 16, 2010
Open-label trial: effect of weekly risedronate immediately after transplantation in kidney recipientsJosé-Vicente Torregrosa, David Fuster, Miguel-Angel Gentil, et al.
Frontiers in Endocrinology|July 28, 2025
Risk factors for glucocorticoid induced osteoporosis in young adultsHelena Florez, Josep Lluis Carrasco, Martina Barberá, et al.
The American Journal of Gastroenterology|October 24, 2003
Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosisNuria Guañabens, Albert Parés, Inmaculada Ros, et al.
Hepatology (Baltimore, Md.)|August 13, 2011
Effects of bilirubin and sera from jaundiced patients on osteoblasts: contribution to the development of osteoporosis in liver diseasesSilvia Ruiz-Gaspà, Angels Martinez-Ferrer, Nuria Guañabens, et al.
The Journal of Steroid Biochemistry and Molecular Biology|February 12, 2011
Oleoyl-estrone is a precursor of an estrone-derived ponderostat signalRuth Vilà, Cristina Cabot, Laura Villarreal, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Seminars in Arthritis and Rheumatism|September 10, 2002
Clinical characteristics and etiologic factors of premenopausal osteoporosis in a group of Spanish womenPilar Peris, Núria Guañabens, Ma Jesús Martínez de Osaba, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 9, 2014
Effect of recent spinal cord injury on wnt signaling antagonists (sclerostin and dkk-1) and their relationship with bone loss. A 12-month prospective studyLaia Gifre, Joan Vidal, Josep L Carrasco, et al.
Endocrine|October 22, 2010
The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblastsAnna Enjuanes, Silvia Ruiz-Gaspà, Pilar Peris, et al.
Endocrine|October 21, 2010
The effect of the alendronate on OPG/RANKL system in differentiated primary human osteoblastsAnna Enjuanes, Silvia Ruiz-Gaspà, Pilar Peris, et al.
Menopause (New York, N.Y.)|July 14, 2009
Search for hidden secondary causes in postmenopausal women with osteoporosisDacia Cerdá Gabaroi, Pilar Peris, Ana Monegal, et al.
Transplantation|April 16, 2010
Open-label trial: effect of weekly risedronate immediately after transplantation in kidney recipientsJosé-Vicente Torregrosa, David Fuster, Miguel-Angel Gentil, et al.
Frontiers in Endocrinology|July 28, 2025
Risk factors for glucocorticoid induced osteoporosis in young adultsHelena Florez, Josep Lluis Carrasco, Martina Barberá, et al.
The American Journal of Gastroenterology|October 24, 2003
Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosisNuria Guañabens, Albert Parés, Inmaculada Ros, et al.
Hepatology (Baltimore, Md.)|August 13, 2011
Effects of bilirubin and sera from jaundiced patients on osteoblasts: contribution to the development of osteoporosis in liver diseasesSilvia Ruiz-Gaspà, Angels Martinez-Ferrer, Nuria Guañabens, et al.
The Journal of Steroid Biochemistry and Molecular Biology|February 12, 2011
Oleoyl-estrone is a precursor of an estrone-derived ponderostat signalRuth Vilà, Cristina Cabot, Laura Villarreal, et al.
Pageof 6